Overview

  • Product nameQX-222
  • Description
    Na+ channel blocker
  • Biological descriptionNa+ channel blocker. Lidocaine derivative.
  • Purity> 99%

Properties

    References for QX-222 (ab120126)

    This product has been referenced in:
    • Undrovinas AI & Makielski JC Blockade of lysophosphatidylcholine-modified cardiac Na channels by a lidocaine derivative QX-222. Am J Physiol 271:H790-7 (1996). Read more (PubMed: 8770124) »
    • Puil E & Carlen PL Attenuation of glutamate-action, excitatory postsynaptic potentials, and spikes by intracellular QX 222 in hippocampal neurons. Neuroscience 11:389-98 (1984). Read more (PubMed: 6144079) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120126.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"